title: Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989-1998.
abstract: OBJECTIVE
  Immunoglobulin A (IgA) autoantibodies to tissue transglutaminase (tTG) are commonly used for screening and diagnosing of celiac disease. We examined the hypothesis that elevated IgA anti-tTG antibodies were associated with higher all-cause mortality risk.
  
  
  METHODS
  The cohort, 2333 men and 2300 women, was based on the follow-up of participants of a representative population-based survey in Southern Germany (KORA/MONICA Augsburg project) conducted in 1989-1990. The endpoint for the vital status with cause of death was the year 1998. The sera drawn at baseline and stored at -80 degrees C, were recently screened with an IgA enzyme-linked immunosorbent assay (ELISA) using human recombinant tTG. Age-standardized mortality rates and age-adjusted hazard ratios were calculated.
  
  
  RESULTS
  From the 4633 sera analyzed, 63 had an IgA anti-tTG concentration>or=7 AU/ml. Of these 63 individuals, 15 died between 1989 and 1998. The age-adjusted hazard ratio (HRa) of all-cause mortality was 1.86 (95% CI: 1.01-3.41) and 3.92 (95% CI: 1.44-10.71) for men and women, respectively. The excess of cancer mortality was even higher with an HR(a) of 2.47 (95% CI: 0.89-6.83) in men and of 6.65 (95% CI: 2.04-21.63) in women.
  
  
  CONCLUSIONS
  Individuals with elevated IgA anti-tTG antibodies had a highly increased mortality risk, particularly due to cancer. New studies are necessary to clarify if this increased risk is due to undiagnosed celiac disease or/and if this elevated IgA anti-tTG antibodies level is a marker of serious diseases like cancer, chronic liver disease or end-stage heart failure.
authors.affiliation: GSF - National Research Center for Environment and Health, Institute of Epidemiology, Neuherberg, Germany.
authors.forename: Marie-Hélène
authors.initials: MH
authors.lastname: Metzger
authors.forename: Margit
authors.initials: M
authors.lastname: Heier
authors.forename: Markku
authors.initials: M
authors.lastname: Mäki
authors.forename: Enzo
authors.initials: E
authors.lastname: Bravi
authors.forename: Andrea
authors.initials: A
authors.lastname: Schneider
authors.forename: Hannelore
authors.initials: H
authors.lastname: Löwel
authors.forename: Thomas
authors.initials: T
authors.lastname: Illig
authors.forename: Detlef
authors.initials: D
authors.lastname: Schuppan
authors.forename: Heinz-Erich
authors.initials: HE
authors.lastname: Wichmann
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D002423:Cause of Death; D015331:Cohort Studies; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood* / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000201:enzymology / Q000401:mortality; D017678:Sex Distribution; D013997:Time Factors; D011503:Transglutaminases / Q000276:immunology*
chemical_list: D007070:Immunoglobulin A; D011503:Transglutaminases